Keywords
Last Name

Karen Quillen, MD

TitleProfessor
InstitutionBoston University School of Medicine
DepartmentPathology & Laboratory Medicine
DivisionClinical Pathology
Address88 E. Newton St Newton Pavilion
Boston MA 02118
Phone(617) 638-7828
ORCID ORCID Icon0000-0002-4243-0864
Other Positions
TitleProfessor
InstitutionBoston University School of Medicine
DepartmentMedicine
DivisionHematology & Medical Oncology

 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Phull P, Quillen K, Hartshorn KL. Acute Oxaliplatin-induced Hemolytic Anemia, Thrombocytopenia, and Renal Failure: Case Report and a Literature Review. Clin Colorectal Cancer. 2016 Nov 23. PMID: 27989485.
    View in: PubMed
  2. Cumming M, Osinski A, O'Hearn L, Waksmonski P, Herman M, Gordon D, Griffiths E, Knox K, McHale E, Quillen K, Rios J, Pisciotto P, Uhl L, DeMaria A, Andrzejewski C. Hemovigilance in Massachusetts and the adoption of statewide hospital blood bank reporting using the National Healthcare Safety Network. Transfusion. 2017 Feb; 57(2):478-483. PMID: 27774608.
    View in: PubMed
  3. Quillen K. The trials and tribulations of chronic transfusion in pediatric sickle cell disease: progress from STOP to TWiTCH? Transfusion. 2016 Jul; 56(7):1673-4. PMID: 27389991.
    View in: PubMed
  4. Lee SY, Meehan RS, Seldin DC, Sloan JM, Quillen K, Shelton A, Brauneis D, Sanchorawala V. Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis. Bone Marrow Transplant. 2016 Oct; 51(10):1318-1322. PMID: 27183092.
    View in: PubMed
  5. Ding Y, Francis J, Kalish J, Deshpande A, Quillen K. Recurrent focal segmental glomerulosclerosis apparently resistant to plasmapheresis improves after surgical repair of arteriovenous fistula aneurysms. Clin Kidney J. 2016 Jun; 9(3):408-10. PMID: 27274825.
    View in: PubMed
  6. Ortega R, Canelli RJ, Quillen K, Mustafa W, Kotova F. VIDEOS IN CLINICAL MEDICINE. Transfusion of Red Cells. N Engl J Med. 2016 Mar 17; 374(11):e12. PMID: 26981950.
    View in: PubMed
  7. Sanchorawala V, Sun F, Quillen K, Sloan JM, Berk JL, Seldin DC. Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience. Blood. 2015 Nov 12; 126(20):2345-7. PMID: 26443620.
    View in: PubMed
  8. Bosch N, Renteria AS, Quillen K, Brauneis D, Santilli J, Kim D, Sanchorawala V. Nonoperative Management of Spontaneous Splenic Rupture in a Patient with Light-Chain Amyloidosis: A Case Report. J Vasc Interv Radiol. 2015 Oct; 26(10):1578-80. PMID: 26408221.
    View in: PubMed
  9. Sanchorawala V, Brauneis D, Shelton AC, Lo S, Sun F, Sloan JM, Quillen K, Seldin DC. Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial. Biol Blood Marrow Transplant. 2015 Aug; 21(8):1445-51. PMID: 25858810.
    View in: PubMed
  10. Freeman B, Brauneis D, Seldin DC, Quillen K, Sloan JM, Renteria AS, Shelton AC, Teschner T, Finn KT, Sanchorawala V. Hospital admissions following outpatient administration of high-dose melphalan and autologous SCT for AL amyloidosis. Bone Marrow Transplant. 2014 Oct; 49(10):1345-6. PMID: 24955784.
    View in: PubMed
  11. Lee SY, Sanchorawala V, Seldin DC, Mark Sloan J, Andrea N, Quillen K. Plerixafor-augmented peripheral blood stem cell mobilization in AL amyloidosis with cardiac involvement: a case series. Amyloid. 2014 Sep; 21(3):149-53. PMID: 24779777.
    View in: PubMed
  12. Quillen K, Luckey CJ. Blood and bombs: blood use after the Boston Marathon bombing of April 15, 2013. Transfusion. 2014 Apr; 54(4):1202-3. PMID: 24724792.
    View in: PubMed
  13. Girnius S, Seldin DC, Meier-Ewert HK, Sloan JM, Quillen K, Ruberg FL, Berk JL, Doros G, Sanchorawala V. Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement. Bone Marrow Transplant. 2014 Mar; 49(3):434-9. PMID: 24317129.
    View in: PubMed
  14. Raman V, Quillen K, Sloan JM. Acquired Glanzmann thrombasthenia associated with Hodgkin lymphoma: rapid reversal of functional platelet defect with ABVD (adriamycin/bleomycin/vinblastine/dacarbazine) chemotherapy. Clin Lymphoma Myeloma Leuk. 2014 Apr; 14(2):e51-4. PMID: 24342105.
    View in: PubMed
  15. Quillen K. In search of plentiful universal donor plasma: what might Landsteiner say? Transfusion. 2013 Aug; 53(8):1863-4. PMID: 23927641.
    View in: PubMed
  16. Walsh M, Merkel PA, Peh CA, Szpirt W, Guillevin L, Pusey CD, De Zoysa J, Ives N, Clark WF, Quillen K, Winters JL, Wheatley K, Jayne D. Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial. Trials. 2013; 14:73. PMID: 23497590.
    View in: PubMed
  17. Tsai SB, Seldin DC, Quillen K, Berk JL, Ruberg FL, Meier-Ewert H, Sloan JM, Doros G, Finn KT, Skinner M, Sanchorawala V. High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center. Blood. 2012 Nov 22; 120(22):4445-6. PMID: 23175664.
    View in: PubMed
  18. Perry JH, Lazar HL, Quillen K, Sloan JM. Successful long-term management of aneurysm-associated chronic disseminated intravascular coagulation with low molecular weight heparin. J Card Surg. 2012 Nov; 27(6):730-5. PMID: 23173861.
    View in: PubMed
  19. Quillen K. Hemolysis from platelet transfusion: call to action for an underreported reaction. Transfusion. 2012 Oct; 52(10):2072-4. PMID: 23110729.
    View in: PubMed
  20. Cowan AJ, Seldin DC, Skinner M, Quillen K, Doros G, Tan J, O'Hara C, Finn KT, Sanchorawala V. Amyloid deposits in the bone marrow of patients with immunoglobulin light chain amyloidosis do not impact stem cell mobilization or engraftment. Biol Blood Marrow Transplant. 2012 Dec; 18(12):1935-8. PMID: 22842332.
    View in: PubMed
  21. Tan JN, Burke PA, Agarwal SK, Mantilla-Rey N, Quillen K. A massive transfusion protocol incorporating a higher FFP/RBC ratio is associated with decreased use of recombinant activated factor VII in trauma patients. Am J Clin Pathol. 2012 Apr; 137(4):566-71. PMID: 22431532.
    View in: PubMed
  22. Quillen K, Caron J, Murphy K. Performance characteristics of two automated solid-phase red cell adherence systems for pretransfusion antibody screening: a cautionary tale. Immunohematology. 2012; 28(4):137-9. PMID: 23421544.
    View in: PubMed
  23. Sanchorawala V, Quillen K, Sloan JM, Andrea NT, Seldin DC. Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study. Haematologica. 2011 Dec; 96(12):1890-2. PMID: 21859734.
    View in: PubMed
  24. Cibeira MT, Sanchorawala V, Seldin DC, Quillen K, Berk JL, Dember LM, Segal A, Ruberg F, Meier-Ewert H, Andrea NT, Sloan JM, Finn KT, Doros G, Blade J, Skinner M. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood. 2011 Oct 20; 118(16):4346-52. PMID: 21828140.
    View in: PubMed
  25. Seldin DC, Andrea N, Berenbaum I, Berk JL, Connors L, Dember LM, Doros G, Fennessey S, Finn K, Girnius S, Lerner A, Libbey C, Meier-Ewert HK, O'Connell R, O'Hara C, Quillen K, Ruberg FL, Sam F, Segal A, Shelton A, Skinner M, Sloan JM, Wiesman JF, Sanchorawala V. High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution. Amyloid. 2011 Jun; 18 Suppl 1:127-9. PMID: 21838459.
    View in: PubMed
  26. Quillen K, Sheldon SL, Daniel-Johnson JA, Lee-Stroka AH, Flegel WA. A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies. Transfusion. 2011 Jan; 51(1):92-6. PMID: 20576015.
    View in: PubMed
  27. Quillen K, Seldin DC, Finn KT, Sanchorawala V. A second course of high-dose melphalan and auto-SCT for the treatment of relapsed AL amyloidosis. Bone Marrow Transplant. 2011 Jul; 46(7):976-80. PMID: 20956955.
    View in: PubMed
  28. Quillen K, Medrano C, Adams S, Peterson B, Hackett J, Leitman SF, Klein HG, Stroncek DF. Screening plateletpheresis donors for HLA antibodies on two high-throughput platforms and correlation with recipient outcome. Transfusion. 2011 Mar; 51(3):504-10. PMID: 20849407.
    View in: PubMed
  29. Wang D, Lane C, Quillen K. Prevalence of RhD variants, confirmed by molecular genotyping, in a multiethnic prenatal population. Am J Clin Pathol. 2010 Sep; 134(3):438-42. PMID: 20716800.
    View in: PubMed
  30. Girnius S, Seldin DC, Quillen K, Dember LM, Segal A, Sanchorawala V. Long-term outcome of patients with monoclonal Ig deposition disease treated with high-dose melphalan and stem cell transplantation. Bone Marrow Transplant. 2011 Jan; 46(1):161-2. PMID: 20383204.
    View in: PubMed
  31. Girnius S, Seldin DC, Skinner M, Finn KT, Quillen K, Doros G, Sanchorawala V. Short and long-term outcome of treatment with high-dose melphalan and stem cell transplantation for multiple myeloma-associated AL amyloidosis. Ann Hematol. 2010 Jun; 89(6):579-84. PMID: 20012043.
    View in: PubMed
  32. Quillen K, Wong E, Scheinberg P, Young NS, Walsh TJ, Wu CO, Leitman SF. Granulocyte transfusions in severe aplastic anemia: an eleven-year experience. Haematologica. 2009 Dec; 94(12):1661-8. PMID: 19996117.
    View in: PubMed
  33. Koenig S, Quillen K. Using neutrophil and lymphocyte VCS indices in ambulatory pediatric patients presenting with fever. Int J Lab Hematol. 2010 Aug 1; 32(4):449-51. PMID: 19930412.
    View in: PubMed
  34. Lee JC, Ahern TP, Chaves FP, Quillen K. Utility of hematologic and volume, conductivity, and scatter parameters from umbilical cord blood in predicting chorioamnionitis. Int J Lab Hematol. 2010 Jun; 32(3):351-9. PMID: 19793112.
    View in: PubMed
  35. Girnius S, Seldin DC, Skinner M, Finn KT, Quillen K, Doros G, Sanchorawala V. Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease. Haematologica. 2009 Jul; 94(7):1029-32. PMID: 19454500.
    View in: PubMed
  36. Daniel-Johnson J, Leitman S, Klein H, Alter H, Lee-Stroka A, Scheinberg P, Pantin J, Quillen K. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Transfusion. 2009 Sep; 49(9):1845-9. PMID: 19453987.
    View in: PubMed
  37. Rosenzweig M, Seldin DC, Remick DG, Skinner M, Quillen K, Oran B, Finn KT, Sanchorawala V. Febrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis: a 'melphalan recall' reaction. Bone Marrow Transplant. 2010 Jan; 45(1):21-4. PMID: 19421171.
    View in: PubMed
  38. Quillen K, Byrne P, Yau YY, Leitman SF. Ten-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte-colony-stimulating factor and dexamethasone. Transfusion. 2009 Mar; 49(3):513-8. PMID: 19243544.
    View in: PubMed
  39. Quillen K, Murphy K. Reducing the risk of mistransfusion. Arch Pathol Lab Med. 2009 Feb; 133(2):176. PMID: 19195959.
    View in: PubMed
  40. Alter D, Grenache DG, Bosler DS, Karcher RE, Nichols J, Rajadhyaksha A, Camelo-Piragua S, Rauch C, Huddleston BJ, Frank EL, Sluss PM, Lewandrowski K, Eichhorn JH, Hall JE, Rahman SS, McPherson RA, Kiechle FL, Hammett-Stabler C, Pierce KA, Kloehn EA, Thomas PA, Walts AE, Madan R, Schlesinger K, Nawgiri R, Bhutani M, Kanber Y, Abati A, Atkins KA, Farrar R, Gopez EV, Jhala D, Griffin S, Jhala K, Jhala N, Bentz JS, Emerson L, Chadwick BE, Barroeta JE, Baloch ZW, Collins BT, Middleton OL, Davis GG, Haden-Pinneri K, Chu AY, Keylock JB, Ramoso R, Thoene CA, Stewart D, Pierce A, Barry M, Aljinovic N, Gardner DL, Barry M, Shields LB, Arnold J, Stewart D, Martin EL, Rakow RJ, Paddock C, Zaki SR, Prahlow JA, Stewart D, Shields LB, Rolf CM, Falzon AL, Hudacki R, Mazzella FM, Bethel M, Zarrin-Khameh N, Gresik MV, Gill R, Karlon W, Etzell J, Deftos M, Karlon WJ, Etzell JE, Wang E, Lu CM, Manion E, Rosenthal N, Wang E, Lu CM, Tang P, Petric M, Schade AE, Hall GS, Oethinger M, Hall G, Picton AR, Hoang L, Imperial MR, Kibsey P, Waites K, Duffy L, Hall GS, Salangsang JA, Bravo LT, Oethinger MD, Veras E, Silva E, Vicens J, Silva E, Keylock J, Hempel J, Rushing E, Posligua LE, Deavers MT, Nash JW, Basturk O, Perle MA, Greco A, Lee P, Maru D, Weydert JA, Stevens TM, Brownlee NA, Kemper AE, Williams HJ, Oliverio BJ, Al-Agha OM, Eskue KL, Newlands SD, Eltorky MA, Puri PK, Royer MC, Rush WL, Tavora F, Galvin JR, Franks TJ, Carter JE, Kahn AG, Lozada Muñoz LR, Houghton D, Land KJ, Nester T, Gildea J, Lefkowitz J, Lacount RA, Thompson HW, Refaai MA, Quillen K, Lopez AO, Goldfinger D, Muram T, Thompson H. Check Sample Abstracts. Am J Clin Pathol. 2009 Feb; 131(2):286-299. PMID: 19176368.
    View in: PubMed
  41. Tam M, Seldin DC, Forbes BM, Connors LH, Skinner M, Oran B, Quillen K, Sanchorawala V. Spontaneous rupture of the liver in a patient with systemic AL amyloidosis undergoing treatment with high-dose melphalan and autologous stem cell transplantation: a case report with literature review. Amyloid. 2009; 16(2):103-7. PMID: 20536404.
    View in: PubMed
  42. Quillen K, Yau YY, Leitman SF. The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience. Transfusion. 2009 Mar; 49(3):421-6. PMID: 19040597.
    View in: PubMed
  43. Quillen K, Lane C, Hu E, Pelton S, Bateman S. Prevalence of ceftriaxone-induced red blood cell antibodies in pediatric patients with sickle cell disease and human immunodeficiency virus infection. Pediatr Infect Dis J. 2008 Apr; 27(4):357-8. PMID: 18316983.
    View in: PubMed
  44. Sanchorawala V, Skinner M, Quillen K, Finn KT, Doros G, Seldin DC. Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation. Blood. 2007 Nov 15; 110(10):3561-3. PMID: 17673601.
    View in: PubMed
  45. Sanchorawala V, Wright DG, Quillen K, Finn KT, Dember LM, Berk JL, Doros G, Fisher C, Skinner M, Seldin DC. Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis. Bone Marrow Transplant. 2007 Sep; 40(6):557-62. PMID: 17589534.
    View in: PubMed
  46. Bauzá G, Hirsch E, Burke P, Quillen K. Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy. Transfusion. 2007 Apr; 47(4):749-51. PMID: 17381636.
    View in: PubMed
  47. Bagdasaryan R, Glasser L, Quillen K, Chaves F, Xu D. Effect of hydroxyurea on immature reticulocyte fraction in sickle cell anemia. Lab Hematol. 2007; 13(3):93-7. PMID: 17984040.
    View in: PubMed
  48. Seldin DC, Anderson JJ, Skinner M, Malek K, Wright DG, Quillen K, Finn K, Oran B, Sanchorawala V. Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65. Blood. 2006 Dec 1; 108(12):3945-7. PMID: 16926284.
    View in: PubMed
  49. Quillen K, Murphy K. Quality improvement to decrease specimen mislabeling in transfusion medicine. Arch Pathol Lab Med. 2006 Aug; 130(8):1196-8. PMID: 16879023.
    View in: PubMed
  50. Weichman K, Dember LM, Prokaeva T, Wright DG, Quillen K, Rosenzweig M, Skinner M, Seldin DC, Sanchorawala V. Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation. Bone Marrow Transplant. 2006 Sep; 38(5):339-43. PMID: 16862166.
    View in: PubMed
  51. Oran B, Malek K, Sanchorawala V, Wright DG, Quillen K, Finn KT, La Valley M, Skinner M, Seldin DC. Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis. Bone Marrow Transplant. 2005 Mar; 35(6):567-75. PMID: 15665842.
    View in: PubMed
  52. Chaves FP, Quillen K, Xu D. Pericardial effusion: a rare presentation of adult T-cell leukemia/lymphoma. Am J Hematol. 2004 Dec; 77(4):381-3. PMID: 15551279.
    View in: PubMed
  53. Luo HY, Adewoye AH, Eung SH, Skelton TP, Quillen K, McMahon L, Steinberg MH, Chui DH. A novel sickle hemoglobin: hemoglobin S-south end. J Pediatr Hematol Oncol. 2004 Nov; 26(11):773-6. PMID: 15543018.
    View in: PubMed
  54. Seldin DC, Anderson JJ, Sanchorawala V, Malek K, Wright DG, Quillen K, Finn KT, Berk JL, Dember LM, Falk RH, Skinner M. Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation. Blood. 2004 Sep 15; 104(6):1888-93. PMID: 15155460.
    View in: PubMed
  55. Sanchorawala V, Wright DG, Seldin DC, Falk RH, Finn KT, Dember LM, Berk JL, Quillen K, Anderson JJ, Comenzo RL, Skinner M. High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial. Bone Marrow Transplant. 2004 Feb; 33(4):381-8. PMID: 14676787.
    View in: PubMed
  56. Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, Anderson JJ, O'Hara C, Finn KT, Libbey CA, Wiesman J, Quillen K, Swan N, Wright DG. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med. 2004 Jan 20; 140(2):85-93. PMID: 14734330.
    View in: PubMed
  57. Sanchorawala V, Wright DG, Seldin DC, Dember LM, Finn K, Falk RH, Berk J, Quillen K, Skinner M. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis. Bone Marrow Transplant. 2001 Oct; 28(7):637-42. PMID: 11704785.
    View in: PubMed
  58. Choufani EB, Sanchorawala V, Ernst T, Quillen K, Skinner M, Wright DG, Seldin DC. Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy. Blood. 2001 Mar 15; 97(6):1885-7. PMID: 11238135.
    View in: PubMed
  59. Quillen K. Hypotensive transfusion reactions in patients taking angiotensin-converting-enzyme inhibitors. N Engl J Med. 2000 Nov 9; 343(19):1422-3. PMID: 11183892.
    View in: PubMed
  60. Quillen K, Berkman EM. Methods of isolation and cryopreservation of stem cells from cord blood. J Hematother. 1996 Apr; 5(2):153-5. PMID: 8723793.
    View in: PubMed
  61. Quillen K, Magarace L, Flanagan J, Berkman EM. Vascular erosion caused by a double-lumen central venous catheter during therapeutic plasma exchange. Transfusion. 1995 Jun; 35(6):510-2. PMID: 7770904.
    View in: PubMed
Karen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department